Questions arise into Emergent's production of COVID-19 vaccine

There are new questions about the Johnson & Johnson vaccine and the Baltimore plant that has been producing it. When 11 News spent several hours at Emergent BioSolution's Bayview facility on Wednesday, the company confirmed on the record for the first time that the manufacturing facility was still waiting for emergency approval from the Food and Drug Administration. In conversations, company executives said it was all just a matter of red tape and approval was imminent. What Emergent didn't discuss was an apparent 15 million dose mistake. A New York Times report published Wednesday night detailed a massive mistake at Emergent's Bayview manufacturing plant that ruined 15 million doses of the vaccine that had to be trashed.